Filtered By:
Management: Insurance
Vaccination: Hepatitis Vaccine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 107 results found since Jan 2013.
A comprehensive screening for hepatitis B and C as an effective means of cancer prevention and as a prerequisite for elimination of chronic viral hepatitis - Data and comments on a discussion
Dtsch Med Wochenschr. 2023 Feb;148(4):175-182. doi: 10.1055/a-1972-4118. Epub 2023 Feb 7.ABSTRACTSince October 2021 in Germany all people with a statutory health insurance aged 35 and older have the right to be tested once for hepatitis B and C in a general preventative examination, regardless of specific risk-factors. This is a milestone on the way of eliminating these infections and also a great contribution to cancer prevention.In the USA the Centers of Disease Control and Prevention in April 2020 recommended a one-time screening for all adults aged 18 and older in addition to testing people with known risk-factors, bec...
Source: Cancer Control - February 7, 2023 Category: Cancer & Oncology Authors: Ingmar Wolffram Source Type: research
Liver Cirrhosis Increases the Risk of Herpes Zoster: A Nationwide Population-based Cohort Study
CONCLUSION: Patients with LC, particularly those who are not currently recommended for HZ vaccination, were at an increased risk of HZ and HZ-related hospitalization compared to the general Korean population.PMID:36746415 | DOI:10.14309/ajg.0000000000002209
Source: Herpes - February 6, 2023 Category: Infectious Diseases Authors: Dongsub Jeon Ye-Jee Kim Seonok Kim Won-Mook Choi Danbi Lee Ju Hyun Shim Kang Mo Kim Young-Suk Lim Han Chu Lee Jonggi Choi Source Type: research
Vaccination Coverage by Age 24 Months Among Children Born During 2018-2019 - National Immunization Survey-Child, United States, 2019-2021
This report describes vaccination coverage by age 24 months using data from the National Immunization Survey-Child (NIS-Child).† Compared with coverage among children born during 2016-2017, coverage among children born during 2018-2019 increased for a majority of recommended vaccines. Coverage was >90% for ≥3 doses of poliovirus vaccine (93.4%), ≥3 doses of hepatitis B vaccine (HepB) (92.7%), ≥1 dose of measles, mumps, and rubella vaccine (MMR) (91.6%), and ≥1 dose of varicella vaccine (VAR) (91.1%); coverage was lowest for ≥2 doses of hepatitis A vaccine (HepA) (47.3%). Vaccination coverage overall was simi...
Source: MMWR Morb Mortal Wkl... - January 12, 2023 Category: Epidemiology Authors: Holly A Hill Michael Chen Laurie D Elam-Evans David Yankey James A Singleton Source Type: research
Significant gaps in hepatitis B vaccination in adults in Viet Nam: Important targets toward hepatitis B elimination by 2030
CONCLUSION: This study depicts a significant unmet need for hepatitis B vaccination in the general adult population in HCMC, Viet Nam. Indeed, the lack of vaccination was unevenly distributed regarding age groups, geographical areas, and socioeconomic statuses, which reveals profound social disparities. Therefore, to achieve hepatitis B elimination goals, besides the current recommendations for infants and risk-based strategies, hepatitis B vaccination should be recommended for the broader population.PMID:36588006 | DOI:10.1016/j.vaccine.2022.12.051
Source: Vaccine - January 1, 2023 Category: Allergy & Immunology Authors: Thanh V Kim Trang N D Pham Duc H Le Diem V B Dao Loc T B Phan Anh Le Amy Trang Hong K Tang Jason J Liu Doan Y Dao Source Type: research
Pneumococcal and influenza vaccination coverage among at-risk adults: A 5-year French national observational study
CONCLUSION: Pneumococcal and influenza vaccination coverage of adults at risk of pneumococcal disease fell well below public health expectations. Invitations for pneumococcal vaccination should be sent by the NHI to high-risk patients. Patient management protocols should include pneumococcal vaccination. Patients with multiple comorbidities are a high-priority population given the large potential health gains offered by pneumococcal vaccination. Commitment of both scientific societies and health authorities is urgently needed to increase vaccination coverage in at-risk populations.PMID:35811205 | DOI:10.1016/j.vaccine.2022.06.071
Source: Vaccine - July 10, 2022 Category: Allergy & Immunology Authors: Benjamin Wyplosz J érôme Fernandes Ariane Sultan Nicolas Roche Fran çois Roubille Paul Loubet Bertrand Foug ère Bruno Moulin Didier Duhot Alexandre Vainchtock Fanny Raguideau Joannie Lortet-Tieulent Emmanuelle Blanc Jennifer Mo ïsi Gwena ël Goussiau Source Type: research
Barriers Against Hepatitis B Vaccination in High-Risk Adults: A Cross-Sectional Study
CONCLUSION: In high-risk adults, the barriers against hepatitis B virus vaccination should be handled by a comprehensive action plan to achieve the WHO 2030 hepatitis elimination target.PMID:35678801 | DOI:10.5152/tjg.2022.21257
Source: The Turkish Journal of Gastroenterology - June 9, 2022 Category: Gastroenterology Authors: Abdullah Tar ık Aslan Ba şak Şaşmazer Yasin Ayar Zeynep Cansu Duran Murat Akova Source Type: research
